• SMA Treatment Spinraza (nusinersen) Shows Positive Results in New Data
  • SMA Patients at Risk of Metabolic Disorder Known as Ketoacidosis, Case Study Shows
  • Proof-of-Concept Study May Have Found New Way of Treating SMA
  • Top 10 SMA Articles of 2016
  • SBMA Patients Prone to Develop Respiratory Problems Due to Reduced Muscle Strength, Study Says
  • FDA Approves Biogen’s Spinraza (nusinersen) As First Approved SMA Drug for Children, Adults
  • Skin Cell Protein Suggested as Potential SMA Disease Severity Marker
  • Researchers Identify Gene Causing Atypical SMA With Brain Degeneration in Infants
  • Steps Taken by Stem Cells in Becoming Neurons Identified in Study, Aiding Cell Replacement Therapies
  • Body Composition Better Measure of Nutritional Needs of SMA Kids than BMI or Weight
  • Nusinersen Found Safe and Effective in Treating Infants with SMA Type 1, Study Reports
  • Good Start Genetics and Roche Join to Make Screening Tool Available to Mothers-to-be